New study seeks safer dosing for cancer drug in patients with liver issues
NCT ID NCT07036133
First seen Feb 17, 2026 · Last updated May 09, 2026 · Updated 10 times
Summary
This study looks at how the body processes the cancer drug pralatrexate in people with advanced solid tumors or blood cancers who also have mild, moderate, or severe liver problems. Researchers will measure drug levels in the blood and track side effects to find the safest dose. The goal is to provide dosing guidance for patients with liver impairment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gabrail Cancer Center
RECRUITINGCanton, Ohio, 44718, United States
Contact
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact
-
Northwestern University - Feinberg School of Medicine
RECRUITINGChicago, Illinois, 60611, United States
Contact
-
TOI Clinical Research
WITHDRAWNCerritos, California, 90703, United States
Conditions
Explore the condition pages connected to this study.